Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples (WB-13)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00734045
Recruitment Status : Completed
First Posted : August 13, 2008
Last Update Posted : December 10, 2008
Information provided by:
Nanogen, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2008
  Study Completion Date : November 2008